Summary
Intratumoral injections of 10 mg cells walls from Propionibacterium granulosum strain KP-45 (PG) were applied in 14 patients with advanced, metastatic stomach (five cases) and colorectal (nine cases) adenocarcinoma. Each patient had his own “twin” control. All patients received no other anticancer treatment, except analgetics and/or palliative surgery. Treatment with PG resulted in partial regression of tumors accompanied by improvement of the clinical state of these patients as well as the reappearance of normal values in blood count biochemical parameters. In each pair of twin cases, survival of the PG-treated patient was longer than the untreated control. The mean survival of PG-treated patients was 23.5 months (4 of 14 patients being still alive after 2.5 years follow-up), while all control patients died with a mean survival period of 6.4 months. The difference between these two patient groups of about 17 month is significant (p>0.01).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baldwin RW, Byers US (1979) Immunoregulation by bacterial organisms and their role in the immunotherapy of cancer. Springer Sem Immunopathol 2:79–100
Bomfort R (1975) Active specific immunotherapy of mouse methyl-cholantrene-induced tumors with Corynebacterium parvum and irradiated tumor cells. Br J Cancer 32:551–557
Gil J, Ortowski T, Nowakowski W, Ko HL, Roszkowski K, Roszkowski W, Szmigielski S, Pulverer G, Jeljaszewicz J (1980) Local immunotherapy of stomach and intestinal carcinoma by Propionibacterium granulosum. Dis Colon Rectum 23:536–543
Janik P, Roszkowski W, Ko HL, Szmigielski S, Pulverer G, Jeljaszewicz J (1980) The in vivo cytostatic effect induced by Propionibacterium granulosum on murine tumor cells. J Cancer Res Clin Oncol 98:51–58
Milas L, Hunter N, Basic I, Mason K, Grdina DJ, Withers HR (1975) Non-specific immunotherapy of murine solid tumors with Corynebacterium granulosum. J Natl Cancer Inst 54:895–902
Pulverer G, Ko HL (1973) Fermentative and serologic studies on Propionibacterium acnes. Appl Environ Microbiol 25:222–229
Roszkowski W, Kobus M, Luczak M, Ko HL, Szmigielski S, Laskowska B, Pulverer G, Jeljaszewicz J (1980) Action of the three species of Propionibacteria on experimental tumor system in mice. Zentralbl Bakteriol [Orig A] 246:405–414
Roszkowski W, Szmigielski S, Ko HL, Pulverer G, Jeljaszewicz J (1982) Effect of three strains of Propionibacteria and cell wall preparations on lymphocytes and macrophages. Zentralbl Bakteriol [Orig A] 246:393–404
Roszkowski W, Roszkowski K, Szmigielski S, Pulverer G, Jeljaszewicz J (1982) Immonostimulatory and antineoplastic activities of Propionibacteria. In: Easmon CSF, Jeljaszewicz J (eds) Medical microbiology. Academic Press, New York London, pp 433–452
Seidenberger HB (1980) Das Tennessee-Antigen, ein neus tumor-assoziiertes Antigen. Tumor Diagn 1:45–48
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gil, J., Badowski, A., Orlowski, T. et al. A 2.5-year follow-up of local immunotherapy of advanced stomach and intestinal adenocarcinoma with propionibacterium granulosum. J Cancer Res Clin Oncol 105, 98–102 (1983). https://doi.org/10.1007/BF00391839
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00391839